Current strategies and findings in clinically relevant post-translational modification-specific proteomics

Expert Review of Proteomics

Volumn 12, Issue 3, 2015, Pages 235-253

  Pagel, Oliver ^a   Loroch, Stefan ^a   Sickmann, Albert ^a,b,c   Zahedi, René P ^a  

^a LEIBNIZ INSTITUT FÜR ANALYTISCHE WISSENSCHAFTEN ISAS E V   (Germany)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

biomarkers; clinical proteomics; degradomics; ERLIC; glycoproteomics; LC MS; phosphoproteomics; PTM; quantification

Indexed keywords

BIOLOGICAL MARKER;

CLINICAL RESEARCH; HUMAN; MASS SPECTROMETRY; MEDICAL RESEARCH; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEOMICS; QUANTITATIVE ANALYSIS; REVIEW; STUDY DESIGN; ANIMAL; CLINICAL MEDICINE; GLYCOSYLATION; PHOSPHORYLATION; PHYSIOLOGY; TRENDS;

ANIMALS; BIOMARKERS; BIOMEDICAL RESEARCH; CLINICAL MEDICINE; GLYCOSYLATION; HUMANS; MASS SPECTROMETRY; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; PROTEOMICS;

EID: 84929572817     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.2015.1042867     Document Type: Review

References (234)

1. UniProt Consortium. UniProt: a hub for protein information. Nucleic Acids Res 2015;43(D1):D204-12
2. Okada M. Post-translational isoprenylation of tryptophan. Biosci Biotechnol Biochem 2011;75(8):1413-17
3. Nolan EM, Walsh CT. Investigations of the MceIJ-catalyzed posttranslational modification of the microcin E492 C-terminus: linkage of ribosomal and nonribosomal peptides to form "trojan horse" antibiotics. Biochemistry 2008; 47(35):9289-99
4. Hornbeck PV, Kornhauser JM, Tkachev S, et al. PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse. Nucleic Acids Res 2012; 40(Database issue):D261-70 . PhosphoSitePlus (PSP) is an online repository providing comprehensive information and tools for the study of post-translational modifications including their involvement in diseases.
5. Thaysen-Andersen M, Packer NH. Advances in LC-MS/MS-based glycoproteomics: getting closer to system-wide site-specific mapping of the Nand O-glycoproteome. Biochim Biophys Acta 2014;1844(9):1437-52
6. Tutturen AE, Fleckenstein B, de Souza GA. Assessing the citrullinome in rheumatoid arthritis synovial fluid with and without enrichment of citrullinated peptides. J Proteome Res 2014;13(6):2867-73
7. Doll S, Burlingame AL. Mass spectrometry-based detection and assignment of protein posttranslational modifications. ACS Chem Biol 2015;10(1): 63-71
8. Hornbeck PV, Zhang B, Murray B, et al. PhosphoSitePlus, 2014: mutations, PTMs and recalibrations. Nucleic Acids Res 2015; 43(Database issue):D512-20
9. Matic I, Ahel I, Hay RT. Reanalysis of phosphoproteomics data uncovers ADP-ribosylation sites. Nat Methods 2012; 9(8):771-2
10. Martens L, Hermjakob H, Jones P, et al. PRIDE: the proteomics identifications database. Proteomics 2005;5(13):3537-45
11. Vizcaino JA, Deutsch EW, Wang R, et al. ProteomeXchange provides globally coordinated proteomics data submission and dissemination. Nat Biotechnol 2014;32(3): 223-6
12. Vaudel M, Burkhart JM, Zahedi RP, et al. PeptideShaker enables reanalysis of MS-derived proteomics data sets. Nat Biotechnol 2015;33(1):22-4
13. Hunter T. The age of crosstalk: phosphorylation, ubiquitination, and beyond. Mol Cell 2007;28(5):730-8
14. Lothrop AP, Torres MP, Fuchs SM. Deciphering post-translational modification codes. FEBS Lett 2013;587(8):1247-57
15. Peng M, Scholten A, Heck AJ, van Breukelen B. Identification of enriched PTM crosstalk motifs from large-scale experimental data sets. J Proteome Res 2014;13(1):249-59
16. Venne AS, Kollipara L, Zahedi RP. The next level of complexity: crosstalk of posttranslational modifications. Proteomics 2014;14(4-5):513-24
17. Pasing Y, Sickmann A, Lewandrowski U. N-glycoproteomics: mass spectrometry-based glycosylation site annotation. Biol Chem 2012;393(4):249-58
18. Di Palma S, Zoumaro-Djayoon A, Peng M, et al. Finding the same needles in the haystack? A comparison of phosphotyrosine peptides enriched by immuno-affinity precipitation and metal-based affinity chromatography. J Proteomics 2013;91: 331-7
19. Beck F, Geiger J, Gambaryan S, et al. Time-resolved characterization of cAMP/ PKA-dependent signaling reveals that platelet inhibition is a concerted process involving multiple signaling pathways. Blood 2014;123(5):e1-e10 . Quantitative phosphoproteomics was used to study time-resolved phosphorylation patterns in human platelets isolated from healthy donors and stimulated with iloprost to study the inhibiting cAMP/ PKA pathway.
20. Loroch S, Zahedi RP, Sickmann A. Highly sensitive phosphoproteomics by tailoring solid-phase extraction to electrostatic repulsion-hydrophilic interaction chromatography. Anal Chem 2015;87(3): 1596-604 .. Sensitive phosphoproteomics workflows are a key demand of clinical research. This publication describes the use of electrostatic repulsion-hydrophilic interaction chromatography as a promising technique for protein phosphorylation studies with limited sample material.
21. Burkhart JM, Schumbrutzki C, Wortelkamp S, et al. Systematic and quantitative comparison of digest efficiency and specificity reveals the impact of trypsin quality on MS-based proteomics. J Proteomics 2012;75(4):1454-62
22. Meyer JG, Kim S, Maltby DA, et al. Expanding proteome coverage with orthogonal-specificity alpha-lytic proteases. Mol Cell Proteomics 2014;13(3):823-35
23. Loroch S, Dickhut C, Zahedi RP, Sickmann A. Phosphoproteomics-more than meets the eye. Electrophoresis 2013;34(11): 1483-92
24. Rogers LD, Overall CM. Proteolytic post-translational modification of proteins: proteomic tools and methodology. Mol Cell Proteomics 2013;12(12):3532-42
25. Pinkse MW, Uitto PM, Hilhorst MJ, et al. Selective isolation at the femtomole level of phosphopeptides from proteolytic digests using 2D-NanoLC-ESI-MS/MS and titanium oxide precolumns. Anal Chem 2004;76(14):3935-43
26. Mithoe SC, Boersema PJ, Berke L, et al. Targeted quantitative phosphoproteomics approach for the detection of phospho-tyrosine signaling in plants. J Proteome Res 2012;11(1):438-48
27. Batth TS, Francavilla C, Olsen JV. Off-Line High-pH Reversed-Phase Fractionation for In-Depth Phosphoproteomics. J Proteome Res 2014;13(12):6176-86
28. Parker BL, Thaysen-Andersen M, Solis N, et al. Site-specific glycan-peptide analysis for determination of N-glycoproteome heterogeneity. J Proteome Res 2013;12(12): 5791-800
29. Peng J, Elias JE, Thoreen CC, et al. Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. J Proteome Res 2003;2(1):43-50
30. Lohrig K, Sickmann A, Lewandrowski U. Strong cation exchange chromatography for analysis of sialylated glycopeptides. Methods Mol Biol 2011;753:299-308
31. Venne AS, Vogtle FN, Meisinger C, et al. Novel highly sensitive, specific, and straightforward strategy for comprehensive N-terminal proteomics reveals unknown substrates of the mitochondrial peptidase Icp55. J Proteome Res 2013;12(9):3823-30
32. Engholm-Keller K, Birck P, Storling J, et al. TiSH-a robust and sensitive global phosphoproteomics strategy employing a combination of TiO2, SIMAC, and HILIC. J Proteomics 2012;75(18):5749-61
33. Zhou H, Di Palma S, Preisinger C, et al. Toward a comprehensive characterization of a human cancer cell phosphoproteome. J Proteome Res 2013;12(1):260-71
34. Cheng K, Chen R, Seebun D, et al. Large-scale characterization of intact N-glycopeptides using an automated glycoproteomic method. J Proteomics 2014;110:145-54
35. Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell 2011;147(2):275-92
36. Kabashima-Niibe A, Higuchi H, Takaishi H, et al. Mesenchymal stem cells regulate epithelial-mesenchymal transition and tumor progression of pancreatic cancer cells. Cancer Sci 2013;104(2):157-64
37. Ficarro SB, Zhang Y, Carrasco-Alfonso MJ, et al. Online nanoflow multidimensional fractionation for high efficiency phosphopeptide analysis. Mol Cell Proteomics 2011;10(11):O111 011064
38. Megger DA, Bracht T, Meyer HE, Sitek B. Label-free quantification in clinical proteomics. Biochim Biophys Acta 2013; 1834(8):1581-90
39. Hu B, Niu X, Cheng L, et al. Discovering cancer biomarkers from clinical samples by protein microarrays. Proteomics Clin Appl 2015;9(1-2):98-110
40. Parker CE, Borchers CH. Mass spectrometry based biomarker discovery, verification, and validation - Quality assurance and control of protein biomarker assays. Mol Oncol 2014;8(4):840-58
41. Manza LL, Stamer SL, Ham AJ, et al. Sample preparation and digestion for proteomic analyses using spin filters. Proteomics 2005;5(7):1742-5
42. Wisniewski JR, Zougman A, Nagaraj N, Mann M. Universal sample preparation method for proteome analysis. Nat Meth 2009;6(5):359-62 . In this paper, a straightforward, flexible and robust sample preparation technique based on molecular weight cut-off filter devices is demonstrated.
43. Hughes CS, Foehr S, Garfield DA, et al. Ultrasensitive proteome analysis using paramagnetic bead technology. Mol Syst Biol 2014;10:757
44. Masuda T, Sugiyama N, Tomita M, Ishihama Y. Microscale phosphoproteome analysis of 10,000 cells from human cancer cell lines. Anal Chem 2011;83(20): 7698-703
45. Lam MP, Lau E, Siu SO, et al. Online combination of reversed-phase/reversedphase and porous graphitic carbon liquid chromatography for multicomponent separation of proteomics and glycoproteomics samples. Electrophoresis 2011;32(21):2930-40
46. Olsen JV, Mann M. Status of large-scale analysis of post-translational modifications by mass spectrometry. Mol Cell Proteomics 2013;12(12):3444-52
47. Zybailov B, Mosley AL, Sardiu ME, et al. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J Proteome Res 2006;5(9): 2339-47
48. Wang W, Zhou H, Lin H, et al. Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards. Anal Chem 2003;75(18):4818-26
49. Vaudel M, Burkhart JM, Breiter D, et al. A complex standard for protein identification, designed by evolution. J Proteome Res 2012;11(10):5065-71
50. Cox J, Hein MY, Luber CA, et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Molecular Cell Proteomics 2014;13(9): 2513-26
51. Luber CA, Cox J, Lauterbach H, et al. Quantitative proteomics reveals subset-specific viral recognition in dendritic cells. Immunity 2010;32(2):279-89
52. Geiger T, Cox J, Ostasiewicz P, et al. Super-SILAC mix for quantitative proteomics of human tumor tissue. Nat Methods 2010;7(5):383-5
53. Schweppe DK, Rigas JR, Gerber SA. Quantitative phosphoproteomic profiling of human non-small cell lung cancer tumors. J Proteomics 2013;91:286-96
54. Boersema PJ, Geiger T, Wisniewski JR, Mann M. Quantification of the N-glycosylated secretome by super-SILAC during breast cancer progression and in human blood samples. Mol Cell Proteomics 2013;12(1):158-71
55. Melo-Braga MN, Schulz M, Liu Q, et al. Comprehensive quantitative comparison of the membrane proteome, phosphoproteome, and sialiome of human embryonic and neural stem cells. Mol Cell Proteomics 2014;13(1):311-28
56. Jentoft N, Dearborn DG. Labeling of proteins by reductive methylation using sodium cyanoborohydride. J Biol Chem 1979;254(11):4359-65
57. Ross PL, Huang YN, Marchese JN, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 2004;3(12):1154-69
58. Treitz C, Cassidy L, Hockendorf A, et al. Quantitative proteome analysis of Caenorhabditis elegans upon exposure to nematicidal Bacillus thuringiensis. J Proteomics 2015;113:337-50
59. Thompson A, Schafer J, Kuhn K, et al. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal Chem 2003;75(8):1895-904
60. Erickson BK, Jedrychowski MP, McAlister GC, et al. Evaluating multiplexed quantitative phosphopeptide analysis on a hybrid quadrupole mass filter/linear ion trap/Orbitrap mass spectrometer. Anal Chem 2015;87(2):1241-9
61. Venne AS, Solari FA, Faden F, et al. An improved workflow for quantitative Nterminal charge-based fractional diagonal chromatography (ChaFRADIC) to study proteolytic events in Arabidopsis thaliana, Proteomics 2015; In press
62. Thingholm TE, Palmisano G, Kjeldsen F, Larsen MR. Undesirable charge-enhancement of isobaric tagged phosphopeptides leads to reduced identification efficiency. J Proteome Res 2010;9(8):4045-52
63. Pichler P, Köcher T, Holzmann J, et al. Peptide labeling with isobaric tags yields higher identification rates using iTRAQ 4-Plex Compared to TMT 6-Plex and iTRAQ 8-Plex on LTQ Orbitrap. Anal Chem 2010;82(15):6549-58
64. Vaudel M, Burkhart JM, Radau S, et al. Integral quantification accuracy estimation for reporter ion-based quantitative proteomics (iQuARI). J Proteome Res 2012;11(10):5072-80
65. Karp NA, Huber W, Sadowski PG, et al. Addressing accuracy and precision issues in iTRAQ quantitation. Mol Cell Proteomics 2010;9(9):1885-97
66. Ting L, Rad R, Gygi SP, Haas W. MS 3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics. Nat Meth 2011;8(11):937-40
67. Zhao Y, Szeto SS, Kong RP, et al. Online two-dimensional porous graphitic carbon/ reversed phase liquid chromatography platform applied to shotgun proteomics and glycoproteomics. Anal Chem 2014;86(24): 12172-9
68. Fahlman RP, Chen W, Overall CM. Absolute proteomic quantification of the activity state of proteases and proteolytic cleavages using proteolytic signature peptides and isobaric tags. J Proteomics 2014;100: 79-91
69. Glibert P, Meert P, Van Steendam K, et al. Phospho-iTRAQ: assessing isobaric labels for the large-scale study of phosphopeptide stoichiometry. J Proteome Res 2015;14(2): 839-49
70. Ahn JM, Sung HJ, Yoon YH, et al. Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer. Mol Cell Proteomics 2014;13(1):30-48 .. A large-scale glycosylation study investigated fucosylated proteins in patient sera as biomarkers for small-cell lung cancer, including multiple reaction monitoring and ELISA validation of candidates.
71. Ren Y, Hao P, Law SK, Sze SK. Hypoxia-induced changes to integrin alpha 3 glycosylation facilitate invasion in epidermoid carcinoma cell line A431. Mol Cell Proteomics 2014;13(11):3126-37
72. Hebert AS, Merrill AE, Bailey DJ, et al. Neutron-encoded mass signatures for multiplexed proteome quantification. Nat Methods 2013;10(4):332-4
73. Hebert AS, Merrill AE, Stefely JA, et al. Amine-reactive neutron-encoded labels for highly plexed proteomic quantitation. Mol Cell Proteomics 2013;12(11):3360-9
74. Frost DC, Greer T, Li L. High-Resolution Enabled 12-Plex DiLeu Isobaric Tags for Quantitative Proteomics. Anal Chem 2015; 87(3):1646-54
75. Mohammed Y, Domanski D, Jackson AM, et al. PeptidePicker: a scientific workflow with web interface for selecting appropriate peptides for targeted proteomics experiments. J Proteomics 2014;106:151-61
76. Domon B, Gallien S. Recent advances in targeted proteomics for clinical applications. Proteomics Clin Appl 2014. [Epub ahead of print]
77. Carr SA, Abbatiello SE, Ackermann BL, et al. Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach. Mol Cell Proteomics 2014;13(3):907-17
78. Abbatiello SE, Mani DR, Schilling B, et al. Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatography-multiple reaction monitoring-MS (LC-MRM-MS). Mol Cell Proteomics 2013;12(9):2623-39 . A standardization approach for multiple reaction monitoring measurements is demonstrated to yield precise inter- and intra-lab results at 11 locations.
79. Percy AJ, Chambers AG, Yang J, et al. Method and platform standardization in MRM-based quantitative plasma proteomics. J Proteomics 2013;95:66-76
80. Goldman R, Sanda M. Targeted methods for quantitative analysis of protein glycosylation. Proteomics Clini Appl 2015; 9(1-2):17-32
81. Narumi R, Murakami T, Kuga T, et al. A strategy for large-scale phosphoproteomics and SRM-based validation of human breast cancer tissue samples. J Proteome Res 2012; 11(11):5311-22
82. Yoneyama T, Ohtsuki S, Ono M, et al. Quantitative targeted absolute proteomics-based large-scale quantification of proline-hydroxylated alpha-fibrinogen in plasma for pancreatic cancer diagnosis. J Proteome Res 2013;12(2):753-62
83. Hernandez B, Parnell A, Pennington SR. Why have so few proteomic biomarkers survived validation? (Sample size and independent validation considerations). Proteomics 2014;14(13-14):1587-92
84. Christin C, Hoefsloot HC, Smilde AK, et al. A critical assessment of feature selection methods for biomarker discovery in clinical proteomics. Mol Cell Proteomics 2013;12(1):263-76
85. Skates SJ, Gillette MA, LaBaer J, et al. Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies. J Proteome Res 2013;12(12):5383-94
86. Kammers K, Cole RN, Tiengwe C, Ruczinski I. Detecting Significant Changes in Protein Abundance. EuPA Open Proteomics 2015;7:11-19
87. Dunkler D, Sanchez-Cabo F, Heinze G. Statistical analysis principles for Omics data. Methods Mol Biol 2011;719:113-31
88. Wheelock AM, Wheelock CE. Trials and tribulations of 'omics data analysis: assessing quality of SIMCA-based multivariate models using examples from pulmonary medicine. Mol Biosyst 2013;9(11):2589-96
89. Ting L, Cowley MJ, Hoon SL, et al. Normalization and statistical analysis of quantitative proteomics data generated by metabolic labeling. Mol Cell Proteomics 2009;8(10):2227-42
90. Margolin AA, Ong SE, Schenone M, et al. Empirical Bayes analysis of quantitative proteomics experiments. PLoS ONE 2009; 4(10):e7454
91. Datta S, Satten GA, Benos DJ, et al. An empirical bayes adjustment to increase the sensitivity of detecting differentially expressed genes in microarray experiments. Bioinformatics 2004;20(2):235-42
92. Wettenhall JM, Smyth GK. limmaGUI: a graphical user interface for linear modeling of microarray data. Bioinformatics 2004;20(18):3705-6
93. Ritchie ME, Phipson B, Wu D, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 2015. [Epub ahead of print]
94. Van Hoof D, Munoz J, Braam SR, et al. Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell 2009;5(2):214-26
95. Kaibuchi K, Sano K, Hoshijima M, et al. Phosphatidylinositol turnover in platelet activation; calcium mobilization and protein phosphorylation. Cell Calcium 1982;3(4-5): 323-35
96. Dephoure N, Zhou C, Villen J, et al. A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci USA 2008;105(31):10762-7
97. Tepper K, Biernat J, Kumar S, et al. Oligomer formation of tau protein hyperphosphorylated in cells. J Biol Chem 2014;289(49):34389-407
98. Ohno M. Roles of eIF2alpha kinases in the pathogenesis of Alzheimer's disease. Front Mol Neurosci 2014;7:22
99. Grundke-Iqbal I, Iqbal K, Tung YC, et al. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 1986;83(13):4913-17
100. Scheuner D, Mierde DV, Song B, et al. Control of mRNA translation preserves endoplasmic reticulum function in beta cells and maintains glucose homeostasis. Nat Med 2005;11(7):757-64
101. Ortsäter H, Grankvist N, Honkanen RE, Sjöholm Å. Protein phosphatases in pancreatic islets. J Endocrinol 2014;221(3): R121-44
102. Meyerovitch J, Backer JM, Kahn CR. Hepatic phosphotyrosine phosphatase activity and its alterations in diabetic rats. J Clin Invest 1989;84(3):976-83
103. Blume-Jensen P, Hunter T. Oncogenic kinase signalling. Nature 2001;411(6835): 355-65
104. Zanivan S, Meves A, Behrendt K, et al. In vivo SILAC-based proteomics reveals phosphoproteome changes during mouse skin carcinogenesis. Cell reports 2013;3(2): 552-66
105. Huelsemann MF, Patz M, Beckmann L, et al. Hypoxia-induced p38 MAPK activation reduces Mcl-1 expression and facilitates sensitivity towards BH3 mimetics in chronic lymphocytic leukemia. Leukemia 2014;29(4):981-4
106. Decker RS, Decker ML, Kulikovskaya I, et al. Myosin-binding protein C phosphorylation, myofibril structure, and contractile function during low-flow ischemia. Circulation 2005;111(7):906-12
107. El-Armouche A, Pohlmann L, Schlossarek S, et al. Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure. J Mol Cell Cardiol 2007;43(2):223-9
108. Schoutsen B, Blom JJ, Verdouw PD, Lamers JM. Calcium transport and phospholamban in sarcoplasmic reticulum of ischemic myocardium. J Mol Cell Cardiol 1989;21(7):719-27
109. Tedford NC, Hall AB, Graham JR, et al. Quantitative analysis of cell signaling and drug action via mass spectrometry-based systems level phosphoproteomics. Proteomics 2009;9(6):1469-87
110. Kumar A, Baycin-Hizal D, Shiloach J, et al. Coupling enrichment and proteomics methods for understanding and treating disease. Proteomics Clin Appl 2015;9(1-2): 33-47
111. Soderblom EJ, Thompson JW, Schwartz EA, et al. Proteomic analysis of ERK1/2-mediated human sickle red blood cell membrane protein phosphorylation. Clin Proteomics 2013;10(1):1
112. Nyman E, Rajan MR, Fagerholm S, et al. A Single Mechanism Can Explain Network-wide Insulin Resistance in Adipocytes from Obese Patients with Type 2 Diabetes. J Biological Chem 2014; 289(48):33215-30
113. Andersson L, Porath J. Isolation of phosphoproteins by immobilized metal (Fe3 +) affinity chromatography. Anal Biochem 1986;154(1):250-4
114. Ruprecht B, Koch H, Medard G, et al. Comprehensive and reproducible phosphopeptide enrichment using Fe-IMAC columns. Mol Cell Proteomics 2015;14(1): 205-15
115. Yu Z, Han G, Sun S, et al. Preparation of monodisperse immobilized Ti(4+) affinity chromatography microspheres for specific enrichment of phosphopeptides. Anal Chim Acta 2009;636(1):34-41
116. de Graaf EL, Giansanti P, Altelaar AF, Heck AJ. Single-step Enrichment by Ti4 +-IMAC and Label-free Quantitation Enables In-depth Monitoring of Phosphorylation Dynamics with High Reproducibility and Temporal Resolution. Mol Cell Proteomics 2014;13(9):2426-34
117. Paulo JA, McAllister FE, Everley RA, et al. Effects of MEK inhibitors GSK1120212 and PD0325901 in vivo using 10-plex quantitative proteomics and phosphoproteomics. Proteomics 2015; 15(2-3):462-73
118. Kelstrup CD, Jersie-Christensen RR, Batth TS, et al. Rapid and Deep Proteomes by Faster Sequencing on a Benchtop Quadrupole Ultra-High-Field Orbitrap Mass Spectrometer. J Proteome Res 2014; 13(12):6187-95
119. Gruhler A, Olsen JV, Mohammed S, et al. Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway. Mol Cell Proteomics 2005;4(3):310-27
120. Olsen JV, Blagoev B, Gnad F, et al. Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006; 127(3):635-48
121. McNulty DE, Annan RS. Hydrophilic interaction chromatography reduces the complexity of the phosphoproteome and improves global phosphopeptide isolation and detection. Mol Cell Proteomics 2008; 7(5):971-80
122. Herskowitz JH, Seyfried NT, Duong DM, et al. Phosphoproteomic analysis reveals site-specific changes in GFAP and NDRG2 phosphorylation in frontotemporal lobar degeneration. J Proteome Res 2010; 9(12):6368-79
123. Gauci S, Helbig AO, Slijper M, et al. Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal Chem 2009; 81(11):4493-501
124. Alpert AJ. Electrostatic repulsion hydrophilic interaction chromatography for isocratic separation of charged solutes and selective isolation of phosphopeptides. Anal Chem 2008;80(1):62-76
125. Chien KY, Liu HC, Goshe MB. Development and application of a phosphoproteomic method using electrostatic repulsion-hydrophilic interaction chromatography (ERLIC), IMAC, and LC-MS/MS analysis to study Marek's Disease Virus infection. J Proteome Res 2011;10(9):4041-53
126. Hao P, Ren Y, Dutta B, Sze SK. Comparative evaluation of electrostatic repulsion-hydrophilic interaction chromatography (ERLIC) and high-pH reversed phase (Hp-RP) chromatography in profiling of rat kidney proteome. J Proteomics 2013;82:254-62
127. Chen X, Wu D, Zhao Y, et al. Increasing phosphoproteome coverage and identification of phosphorylation motifs through combination of different HPLC fractionation methods. J Chromatogr B Analyt Technol Biomed Life Sci 2011; 879(1):25-34
128. Gan CS, Guo T, Zhang H, et al. A comparative study of electrostatic repulsion-hydrophilic interaction chromatography (ERLIC) versus SCX-IMAC-based methods for phosphopeptide isolation/enrichment. J Proteome Res 2008;7(11):4869-77
129. Loroch S, Schommartz T, Brune W, et al. Multidimensional electrostatic repulsion- hydrophilic interaction chromatography (ERLIC) for quantitative analysis of the proteome and phosphoproteome in clinical and biomedical research. Biochi Biophys Acta 2015;1854(5(0):460-8
130. Dickhut C, Feldmann I, Lambert J, Zahedi RP. Impact of Digestion Conditions on Phosphoproteomics. J Proteome Res 2014;13(6):2761-70
131. Glatter T, Ludwig C, Ahrne E, et al. Large-scale quantitative assessment of different in-solution protein digestion protocols reveals superior cleavage efficiency of tandem Lys-C/trypsin proteolysis over trypsin digestion. J Proteome Res 2012; 11(11):5145-56
132. Bian Y, Ye M, Song C, et al. Improve the coverage for the analysis of phosphoproteome of HeLa cells by a tandem digestion approach. J Proteome Res 2012;11(5):2828-37
133. Gonczarowska-Jorge H, Dell'Aica M, Dickhut C, RP Z. Variable digestion strategies for phosphoproteomics analysis. Methods Mol Biol Clifton, N.J 2015; In press
134. Taus T, Kocher T, Pichler P, et al. Universal and confident phosphorylation site localization using phosphoRS. J Proteome Res 2011;10(12):5354-62
135. Vaudel M, Breiter D, Beck F, et al. Dscore: a search engine independent MD-score. Proteomics 2013;13(6):1036-41
136. Fermin D, Walmsley SJ, Gingras AC, et al. LuciPHOr: algorithm for phosphorylation site localization with false localization rate estimation using modified target-decoy approach. Mol Cell Proteomics 2013; 12(11):3409-19
137. Savitski MM, Lemeer S, Boesche M, et al. Confident phosphorylation site localization using the Mascot Delta Score. Mol Cell Proteomics 2011;10(2):M110 003830
138. Beausoleil SA, Villen J, Gerber SA, et al. A probability-based approach for high-throughput protein phosphorylation analysis and site localization. Nat Biotechnol 2006;24(10):1285-92
139. Syka JE, Coon JJ, Schroeder MJ, et al. Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc Natl Acad Sci USA 2004. 101(26):9528-33
140. Frese CK, Altelaar AF, van den Toorn H, et al. Toward full peptide sequence coverage by dual fragmentation combining electron-transfer and higher-energy collision dissociation tandem mass spectrometry. Anal Chem 2012;84(22):9668-73
141. Schroeder MJ, Shabanowitz J, Schwartz JC, et al. A neutral loss activation method for improved phosphopeptide sequence analysis by quadrupole ion trap mass spectrometry. Anal Chem 2004;76(13):3590-8
142. Fleitz A, Nieves E, Madrid-Aliste C, et al. Enhanced detection of multiply phosphorylated peptides and identification of their sites of modification. Anal Chem 2013;85(18):8566-76
143. Halim A, Brinkmalm G, Ruetschi U, et al. Site-specific characterization of threonine, serine, and tyrosine glycosylations of amyloid precursor protein/amyloid beta-peptides in human cerebrospinal fluid. Proc Natl Acad Sci USA 2011;108(29): 11848-53
144. Vakhrushev SY, Steentoft C, Vester-Christensen MB, et al. Enhanced mass spectrometric mapping of the human GalNAc-type O-glycoproteome with SimpleCells. Mol Cell Proteomics 2013; 12(4):932-44
145. Solis D, Bovin NV, Davis AP, et al. A guide into glycosciences: How chemistry, biochemistry and biology cooperate to crack the sugar code. Biochim Biophys Acta 2015; 1850(1):186-235
146. Mitra N, Sinha S, Ramya TN, Surolia A. N-linked oligosaccharides as outfitters for glycoprotein folding, form and function. Trends Biochem Sci 2006;31(3):156-63
147. Shental-Bechor D, Levy Y. Effect of glycosylation on protein folding: a close look at thermodynamic stabilization. Proc Natl Acad Sci USA 2008;105(24):8256-61
148. Parodi AJ. Reglucosylation of glycoproteins and quality control of glycoprotein folding in the endoplasmic reticulum of yeast cells. Biochim Biophys Acta 1999;1426(2):287-95
149. Yoshida Y, Adachi E, Fukiya K, et al. Glycoprotein-specific ubiquitin ligases recognize N-glycans in unfolded substrates. EMBO Rep 2005;6(3):239-44
150. Helenius A, Aebi M. Intracellular functions of N-linked glycans. Science 2001; 291(5512):2364-9
151. Tate MD, Job ER, Deng YM, et al. Playing hide and seek: how glycosylation of the influenza virus hemagglutinin can modulate the immune response to infection. Viruses 2014;6(3):1294-316
152. Christiansen MN, Chik J, Lee L, et al. Cell surface protein glycosylation in cancer. Proteomics 2014;14(4-5):525-46
153. Stuchlova Horynova M, Raska M, Clausen H, Novak J. Aberrant O-glycosylation and anti-glycan antibodies in an autoimmune disease IgA nephropathy and breast adenocarcinoma. Cell Mol Life Sci 2013;70(5):829-39
154. Schedin-Weiss S, Winblad B, Tjernberg LO . The role of protein glycosylation in Alzheimer disease. FEBS J 2014;281(1): 46-62
155. Zhu Y, Shan X, Yuzwa SA, Vocadlo DJ. The Emerging Link between O-GlcNAc and Alzheimer Disease. J Biol Chem 2014; 289(50):34472-81
156. Grigorian A, Mkhikian H, Li CF, et al. Pathogenesis of multiple sclerosis via environmental and genetic dysregulation of N-glycosylation. Semin Immunopathol 2012;34(3):415-24
157. Xu YX, Ashline D, Liu L, et al. The glycosylation-dependent interaction of perlecan core protein with LDL: implications for atherosclerosis. J Lipid Res 2015;56(2):266-76
158. Willig TB, Breton-Gorius J, Elbim C, et al. Macrothrombocytopenia with abnormal demarcation membranes in megakaryocytes and neutropenia with a complete lack of sialyl-Lewis-X antigen in leukocytes-a new syndrome? Blood 2001;97(3):826-8
159. Brooks AR, Sim D, Gritzan U, et al. Glycoengineered factor IX variants with improved pharmacokinetics and subcutaneous efficacy. J Thromb Haemost 2013;11(9):1699-706
160. Ma J, Hart GW. Protein O-GlcNAcylation in diabetes and diabetic complications. Expert Rev Proteomics 2013;10(4):365-80
161. Scott DW, Patel RP. Endothelial heterogeneity and adhesion molecules Nglycosylation: implications in leukocyte trafficking in inflammation. Glycobiology 2013;23(6):622-33
162. Zhang Y, Jiao J, Yang P, Lu H. Mass spectrometry-based N-glycoproteomics for cancer biomarker discovery. Clin Proteomics 2014;11(1):18
163. Song E, Mayampurath A, Yu CY, et al. Glycoproteomics: Identifying the Glycosylation of Prostate Specific Antigen at Normal and High Isoelectric Points by LCMS/ MS. J Proteome Res 2014;13(12): 5570-80
164. Yen TY, Macher BA, McDonald CA, et al. Glycoprotein profiles of human breast cells demonstrate a clear clustering of normal/ benign versus malignant cell lines and basal versus luminal cell lines. J Proteome Res 2012;11(2):656-67
165. Malaguarnera G, Giordano M, Paladina I, et al. Serum markers of hepatocellular carcinoma. Dig Dis Sci 2010;55(10): 2744-55
166. Cho HJ, Kim SS, Ahn SJ, et al. Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B. Clin Mol Hepatol 2014;20(4):347-54
167. Bertino G, Ardiri A, Malaguarnera M, et al. Hepatocellualar carcinoma serum markers. Semin Oncol 2012;39(4):410-33
168. Lee JH, Cho CH, Kim SH, et al. Semi-quantitative Measurement of a Specific Glycoform Using a DNA-tagged Antibody and Lectin Affinity Chromatography for Glyco-biomarker Development. Mol Cell Proteomics 2015;14(3):782-95
169. Palmisano G, Parker BL, Engholm-Keller K , et al. A novel method for the simultaneous enrichment, identification, and quantification of phosphopeptides and sialylated glycopeptides applied to a temporal profile of mouse brain development. Mol Cell Proteomics 2012; 11(11):1191-202
170. Lewandrowski U, Zahedi RP, Moebius J, et al. Enhanced N-glycosylation site analysis of sialoglycopeptides by strong cation exchange prefractionation applied to platelet plasma membranes. Mol Cell Proteomics 2007;6(11):1933-41
171. Zhu J, Sun Z, Cheng K, et al. Comprehensive mapping of protein N-glycosylation in human liver by combining hydrophilic interaction chromatography and hydrazide chemistry. J Proteome Res 2014;13(3):1713-21
172. Ma C, Zhao X, Han H, et al. N-linked glycoproteome profiling of human serum using tandem enrichment and multiple fraction concatenation. Electrophoresis 2013;34(16):2440-50
173. Yin X, Bern M, Xing Q, et al. Glycoproteomic analysis of the secretome of human endothelial cells. Mol Cell Proteomics 2013;12(4):956-78
174. Palmisano G, Lendal SE, Engholm-Keller K, et al. Selective enrichment of sialic acid-containing glycopeptides using titanium dioxide chromatography with analysis by HILIC and mass spectrometry. Nat Protoc 2010;5(12):1974-82
175. Beck F, Lewandrowski U, Wiltfang M, et al. The good, the bad, the ugly: Validating the mass spectrometric analysis of modified peptides. Proteomics 2011;11(6): 1099-109
176. Levery SB, Steentoft C, Halim A, et al. Advances in mass spectrometry driven O-glycoproteomics. Biochim Biophys Acta 2015;1850(1):33-42
177. Froehlich JW, Dodds ED, Wilhelm M, et al. A classifier based on accurate mass measurements to aid large scale, unbiased glycoproteomics. Mol Cell Proteomics 2013;12(4):1017-25
178. Lewandrowski U, Lohrig K, Zahedi R, et al. Glycosylation Site Analysis of Human Platelets by Electrostatic Repulsion Hydrophilic Interaction Chromatography. Clin Proteom 2008;4(1-2):25-36
179. Zhang H, Guo T, Li X, et al. Simultaneous characterization of glyco- and phosphoproteomes of mouse brain membrane proteome with electrostatic repulsion hydrophilic interaction chromatography. Mol Cell Proteomics 2010;9(4):635-47
180. Cao L, Yu L, Guo Z, et al. Application of a strong anion exchange material in electrostatic repulsion-hydrophilic interaction chromatography for selective enrichment of glycopeptides. J Chromatogr A 2013;1299:18-24
181. Hao P, Guo T, Sze SK. Simultaneous analysis of proteome, phospho- and glycoproteome of rat kidney tissue with electrostatic repulsion hydrophilic interaction chromatography. PLoS One 2011;6(2):e16884
182. Blobel G, Dobberstein B. Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma. J Cell Biol 1975;67(3):835-51
183. Silver P, Goodson H. Nuclear protein transport. Crit Rev Biochem Mol Biol 1989;24(4):419-35
184. Pfanner N, Hartl FU, Neupert W. Import of proteins into mitochondria: a multi-step process. Eur J Biochem 1988;175(2):205-12
185. Chung JJ, Shikano S, Hanyu Y, Li M. Functional diversity of protein C-termini: more than zipcoding? Trends Cell Biol 2002;12(3):146-50
186. Lopez-Otin C, Bond JS. Proteases: multifunctional enzymes in life and disease. J Biol Chem 2008;283(45):30433-7
187. Nerelius C, Alvelius G, Jornvall H. N-terminal segment of proinsulin C-peptide active in insulin interaction/desaggregation. Biochem Biophys Res Commun 2010; 403(3-4):462-7
188. Hildebrand D, Merkel P, Eggers LF, Schluter H. Proteolytic processing of angiotensin-I in human blood plasma. PLoS One 2013;8(5):e64027
189. Kurokawa M, Kornbluth S. Caspases and Kinases in a Death Grip. Cell 2009;138(5): 838-54
190. Gervais FG, Thornberry NA, Ruffolo SC, et al. Caspases cleave focal adhesion kinase during apoptosis to generate a FRNK-like polypeptide. J Biol Chem 1998;273(27): 17102-8
191. Petrera A, Lai ZW, Schilling O. Carboxyterminal protein processing in health and disease: key actors and emerging technologies. J Proteome Res 2014;13(11): 4497-504
192. Mossmann D, Vogtle FN, Taskin AA, et al. Amyloid-beta peptide induces mitochondrial dysfunction by inhibition of preprotein maturation. Cell Metab 2014;20(4):662-9
193. McCarty SM, Percival SL. Proteases and Delayed Wound Healing. Adv Wound Care 2013;2(8):438-47
194. Csiszar A, Kutay B, Wirth S, et al. Interleukin-like epithelial-to-mesenchymal transition inducer activity is controlled by proteolytic processing and plasminogen-urokinase plasminogen activator receptor system-regulated secretion during breast cancer progression. Breast Cancer Res 2014;16(5):433
195. Smith H, Edman P, Owen JA. N-Terminal amino-acids of human haptoglobins. Nature 1962;193:286-7
196. Edman P. A method for the determination of amino acid sequence in peptides. Arch Biochem 1949;22(3):475
197. Agard NJ, Wells JA. Methods for the proteomic identification of protease substrates. Curr Opin Chem Biol 2009; 13(5-6):503-9
198. Tanco S, Gevaert K, Van Damme P. Cterminomics: Targeted analysis of natural and post-translationally modified protein and peptide C-termini. Proteomics 2015; 15(5-6):903-14
199. Gevaert K, Goethals M, Martens L, et al. Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat Biotechnol 2003;21(5):566-9
200. Vogtle FN, Wortelkamp S, Zahedi RP, et al. Global analysis of the mitochondrial N-proteome identifies a processing peptidase critical for protein stability. Cell 2009; 139(2):428-39
201. Holmberg C, Ghesquiere B, Impens F, et al. Mapping proteolytic processing in the secretome of gastric cancer-associated myofibroblasts reveals activation of MMP-1, MMP-2, and MMP-3. J Proteome Res 2013;12(7):3413-22
202. Staes A, Van Damme P, Helsens K, et al. Improved recovery of proteome-informative, protein N-terminal peptides by combined fractional diagonal chromatography (COFRADIC). Proteomics 2008;8(7): 1362-70
203. Kleifeld O, Doucet A, auf dem Keller U, et al. Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products. Nat Biotechnol 2010;28(3):281-8
204. auf dem Keller U, Prudova A, Eckhard U, et al. Systems-level analysis of proteolytic events in increased vascular permeability and complement activation in skin inflammation. Sci Signal 2013;6(258):rs2
205. Wilson CH, Indarto D, Doucet A, et al. Identifying natural substrates for dipeptidyl peptidases 8 and 9 using terminal amine isotopic labeling of substrates (TAILS) reveals in vivo roles in cellular homeostasis and energy metabolism. J Biol Chem 2013; 288(20):13936-49
206. Sabino F, Hermes O, Egli FE, et al. In Vivo Assessment of Protease Dynamics in Cutaneous Wound Healing by Degradomics Analysis of Porcine Wound Exudates. Mol Cell Proteomics 2015;14(2):354-70
207. Prudova A, Serrano K, Eckhard U, et al. TAILS N-terminomics of human platelets reveals pervasive metalloproteinase-dependent proteolytic processing in storage. Blood 2014;124(26): e49-60
208. Venne AS, Zahedi RP. The potential of fractional diagonal chromatography strategies for the enrichment of post-translational modifications. EuPA Open Proteomics 2014;4(0):165-70
209. Breuker K, Jin M, Han X, et al. Top-Down Identification and Characterization of Biomolecules by Mass Spectrometry. J Am Soc Mass Spectrom 2008;19(8):1045-53
210. Catherman AD, Skinner OS, Kelleher NL. Top Down proteomics: facts and perspectives. Biochem Biophys Res Commun 2014;445(4):683-93
211. Barnidge DR, Dasari S, Botz CM, et al. Using mass spectrometry to monitor monoclonal immunoglobulins in patients with a monoclonal gammopathy. J Proteome Res 2014;13(3):1419-27
212. Mao P, Wang D. Top-down proteomics of a drop of blood for diabetes monitoring. J Proteome Res 2014;13(3):1560-9
213. Seeley EH, Caprioli RM. MALDI imaging mass spectrometry of human tissue: method challenges and clinical perspectives. Trends Biotechnol 2011;29(3):136-43
214. Rauser S, Marquardt C, Balluff B, et al. Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry. J Proteome Res 2010; 9(4):1854-63
215. Smith LM, Kelleher NL. Proteoform: a single term describing protein complexity. Nat Methods 2013;10(3):186-7
216. Tran JC, Zamdborg L, Ahlf DR, et al. Mapping intact protein isoforms in discovery mode using top-down proteomics. Nature 2011;480(7376):254-8
217. Kellie JF, Catherman AD, Durbin KR, et al. Robust analysis of the yeast proteome under 50 kDa by molecular-mass-based fractionation and top-down mass spectrometry. Anal Chem 2012;84(1): 209-15
218. Catherman AD, Durbin KR, Ahlf DR, et al. Large-scale top-down proteomics of the human proteome: membrane proteins, mitochondria, and senescence. Mol Cell Proteomics 2013;12(12):3465-73
219. Ntai I, Kim K, Fellers RT, et al. Applying label-free quantitation to top down proteomics. Anal Chem 2014;86(10): 4961-8
220. Rhoads TW, Rose CM, Bailey DJ, et al. Neutron-encoded mass signatures for quantitative top-down proteomics. Anal Chem 2014;86(5):2314-19
221. Nagaraj N, Wisniewski JR, Geiger T, et al. Deep proteome and transcriptome mapping of a human cancer cell line. Mol Syst Biol 2011;7:548
222. Hebert AS, Richards AL, Bailey DJ, et al. The one hour yeast proteome. Mol Cell Proteomics 2014;13(1):339-47
223. Nguyen LK, Kolch W, Kholodenko BN. When ubiquitination meets phosphorylation: a systems biology perspective of EGFR/MAPK signalling. Cell Commun Signal 2013;11:52
224. Hietakangas V, Anckar J, Blomster HA, et al. PDSM, a motif for phosphorylation-dependent SUMO modification. Proc Natl Acad Sci USA 2006;103(1):45-50
225. Yang WH, Kim JE, Nam HW, et al. Modification of p53 with O-linked Nacetylglucosamine regulates p53 activity and stability. Nat Cell Biol 2006;8(10):1074-83
226. Cheung P, Tanner KG, Cheung WL, et al. Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol Cell 2000;5(6):905-15
227. Kowenz-Leutz E, Pless O, Dittmar G, et al. Crosstalk between C/EBPb phosphorylation, arginine methylation, and SWI/SNF/ Mediator implies an indexing transcription factor code. EMBO J 2010;29(6):1105-15
228. Smith LE, White MY. The role of post-translational modifications in acute and chronic cardiovascular disease. Proteomics Clin Appl 2014;8(7-8):506-21
229. Sajic T, Liu Y, Aebersold R. Using data-independent, high resolution mass spectrometry in protein biomarker research: Perspectives and clinical applications. Proteomics. Clin Appl 2014. [Epub ahead of print]
230. Liu Y, Chen J, Sethi A, et al. Glycoproteomic analysis of prostate cancer tissues by SWATH mass spectrometry discovers N-acylethanolamine acid amidase and protein tyrosine kinase 7 as signatures for tumor aggressiveness. Mol Cell Proteomics 2014;13(7):1753-68 . The glycoproteomic investigation of different types of prostate cancer by SWATH-mass spectrometry identifies N-acylethanolamine acid amidase and protein tyrosine kinase 7 as novel potential biomarkers to define tumor aggressiveness.
231. Guo T, Kouvonen P, Koh CC, et al. Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps. Nat Med 2015; 21(4):407-13 .. In this publication, a straighforward sample preparation method is used in conjunction with quantitative SWATH-mass spectrometry to distinguish between renal cancer tissue samples and healthy tissue of different individuals.
232. Nagel T, Meyer B. Simultaneous characterization of sequence polymorphisms, glycosylation and phosphorylation of fibrinogen in a direct analysis by LC-MS. Biochim Biophys Acta 2014;1844(12): 2284-9
233. Sidoli S, Schwammle V, Ruminowicz C, et al. Middle-down hybrid chromatography/ tandem mass spectrometry workflow for characterization of combinatorial post-translational modifications in histones. Proteomics 2014;14(19):2200-11
234. Diehl HC, Beine B, Elm J, et al. The challenge of on-tissue digestion for MALDI MSI- a comparison of different protocols to improve imaging experiments. Anal Bioanal Chem 2015;407(8):2223-43